Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth

References

• Bremnes RM, Dønnem T, Al-Saad S, Al-Shibli K, Andersen S, Sirera R, et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol 2011; 6:209 - 17; http://dx.doi.org/10.1097/JTO.0b013e3181f8a1bd; PMID: 21107292
   PubMed Web of Science ®Google Scholar
• Hisatomi K, Mukae H, Sakamoto N, Ishimatsu Y, Kakugawa T, Hara S, et al. Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells. BMC Pulm Med 2012; 12:24; http://dx.doi.org/10.1186/1471-2466-12-24; PMID: 22694981
   PubMed Web of Science ®Google Scholar
• Zhao XY, Zeng X, Li XM, Wang TL, Wang BE. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells. Clin Exp Pharmacol Physiol 2009; 36:963 - 8; http://dx.doi.org/10.1111/j.1440-1681.2009.05194.x; PMID: 19413596
   PubMed Web of Science ®Google Scholar
• Jin D, Fan J, Wang L, Thompson LF, Liu A, Daniel BJ, et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70:2245 - 55; http://dx.doi.org/10.1158/0008-5472.CAN-09-3109; PMID: 20179192
   PubMed Web of Science ®Google Scholar
• Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010; 29:5346 - 58; http://dx.doi.org/10.1038/onc.2010.292; PMID: 20661219
   PubMed Web of Science ®Google Scholar
• Choi K, Lee K, Ryu SW, Im M, Kook KH, Choi C. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19. Mol Vis 2012; 18:1010 - 20; PMID: 22550395
   PubMed Web of Science ®Google Scholar
• Furuta S, Watanabe L, Doi S, Horiuchi H, Matsumoto K, Kuzumaki N, et al. Subdiaphragmatic vagotomy increases the sensitivity of lumbar Aδ primary afferent neurons along with voltage-dependent potassium channels in rats. Synapse 2012; 66:95 - 105; http://dx.doi.org/10.1002/syn.20982; PMID: 21905127
   PubMed Web of Science ®Google Scholar
• Gessi S, Merighi S, Sacchetto V, Simioni C, Borea PA. Adenosine receptors and cancer. Biochim Biophys Acta 2011; 1808:1400 - 12; http://dx.doi.org/10.1016/j.bbamem.2010.09.020; PMID: 20888788
   PubMed Web of Science ®Google Scholar
• Fishman P, Bar-Yehuda S, Synowitz M, Powell JD, Klotz KN, Gessi S, et al. Adenosine receptors and cancer. Handb Exp Pharmacol 2009; 193:399 - 441; http://dx.doi.org/10.1007/978-3-540-89615-9_14; PMID: 19639290
   PubMedGoogle Scholar
• Visner GA, Liu F, Bizargity P, Liu H, Liu K, Yang J, et al. Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses. Transplantation 2009; 88:330 - 8; http://dx.doi.org/10.1097/TP.0b013e3181ae3392; PMID: 19667934
   PubMed Web of Science ®Google Scholar
• Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 2006; 103:13132 - 7; http://dx.doi.org/10.1073/pnas.0605251103; PMID: 16916931
   PubMed Web of Science ®Google Scholar
• Ahmad A, Ahmad S, Glover L, Miller SM, Shannon JM, Guo X, et al. Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc Natl Acad Sci U S A 2009; 106:10684 - 9; http://dx.doi.org/10.1073/pnas.0901326106; PMID: 19541651
   PubMed Web of Science ®Google Scholar
• Waller JR, Murphy GJ, Metcalfe MS, Bicknell GR, Saunders RN, Margolin SB, et al. Effects of pirfenidone on vascular smooth muscle cell proliferation and intimal hyperplasia following arterial balloon injury. Transplant Proc 2001; 33:3816 - 8; http://dx.doi.org/10.1016/S0041-1345(01)02615-X; PMID: 11750625
   PubMed Web of Science ®Google Scholar
• Torigoe K, Nakahara K, Rahmadi M, Yoshizawa K, Horiuchi H, Hirayama S, et al. Usefulness of olanzapine as an adjunct to opioid treatment and for the treatment of neuropathic pain. Anesthesiology 2012; 116:159 - 69; http://dx.doi.org/10.1097/ALN.0b013e31823c7e56; PMID: 22126917
   PubMed Web of Science ®Google Scholar
• Scheibner KA, Boodoo S, Collins S, Black KE, Chan-Li Y, Zarek P, et al. The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. Am J Respir Cell Mol Biol 2009; 40:251 - 9; http://dx.doi.org/10.1165/rcmb.2008-0168OC; PMID: 18703794
   PubMed Web of Science ®Google Scholar
• Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 2010; 330:827 - 30; http://dx.doi.org/10.1126/science.1195300; PMID: 21051638
   PubMed Web of Science ®Google Scholar
• Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell 2010; 17:135 - 47; http://dx.doi.org/10.1016/j.ccr.2009.12.041; PMID: 20138012
   PubMed Web of Science ®Google Scholar
• Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008; 99:1375 - 9; http://dx.doi.org/10.1038/sj.bjc.6604662; PMID: 18797460
   PubMed Web of Science ®Google Scholar
• Saigusa S, Toiyama Y, Tanaka K, Yokoe T, Okugawa Y, Fujikawa H, et al. Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int J Oncol 2011; 38:655 - 63; http://dx.doi.org/10.3892/ijo.2011.906; PMID: 21240461
   PubMed Web of Science ®Google Scholar
• Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59:5002 - 11; PMID: 10519415
   PubMed Web of Science ®Google Scholar
• Fromigué O, Louis K, Dayem M, Milanini J, Pages G, Tartare-Deckert S, et al. Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival. Oncogene 2003; 22:8487 - 97; http://dx.doi.org/10.1038/sj.onc.1206918; PMID: 14627989
   PubMed Web of Science ®Google Scholar
• Cronstein BN. Adenosine receptors and fibrosis: a translational review. F1000 Biol Rep 2011; 3:21; http://dx.doi.org/10.3410/B3-21; PMID: 22003368
   PubMedGoogle Scholar
• Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 2007; 14:1315 - 23; http://dx.doi.org/10.1038/sj.cdd.4402132; PMID: 17396131
   PubMed Web of Science ®Google Scholar
• Fernández P, Trzaska S, Wilder T, Chiriboga L, Blackburn MR, Cronstein BN, et al. Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine. Am J Pathol 2008; 172:1675 - 82; http://dx.doi.org/10.2353/ajpath.2008.070952; PMID: 18467695
   PubMed Web of Science ®Google Scholar
• Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN. Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 2004; 164:1887 - 92; http://dx.doi.org/10.1016/S0002-9440(10)63749-2; PMID: 15161625
   PubMed Web of Science ®Google Scholar
• Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth--bystanders turning into key players. Curr Opin Genet Dev 2009; 19:67 - 73; http://dx.doi.org/10.1016/j.gde.2009.01.003; PMID: 19211240
   PubMed Web of Science ®Google Scholar
• Paunescu V, Bojin FM, Tatu CA, Gavriliuc OI, Rosca A, Gruia AT, et al. Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med 2011; 15:635 - 46; http://dx.doi.org/10.1111/j.1582-4934.2010.01044.x; PMID: 20184663
   PubMed Web of Science ®Google Scholar
• Kuzumaki N, Suzuki A, Narita M, Hosoya T, Nagasawa A, Imai S, et al. Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer. PLoS One 2012; 7:e44368; http://dx.doi.org/10.1371/journal.pone.0044368; PMID: 23144692
   PubMedGoogle Scholar
• Escudero C, Bertoglia P, Hernadez M, Celis C, Gonzalez M, Aguayo C, et al. Impaired A2A adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia. Purinergic Signal 2013; 9:215 - 26; http://dx.doi.org/10.1007/s11302-012-9341-4; PMID: 23179048
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11:85 - 95; http://dx.doi.org/10.1038/nrc2981; PMID: 21258394
   PubMed Web of Science ®Google Scholar
• Locasale JW, Cantley LC. Altered metabolism in cancer. BMC Biol 2010; 8:88; http://dx.doi.org/10.1186/1741-7007-8-88; PMID: 20598111
   PubMed Web of Science ®Google Scholar
• Desai A, Victor-Vega C, Gadangi S, Montesinos MC, Chu CC, Cronstein BN. Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol Pharmacol 2005; 67:1406 - 13; http://dx.doi.org/10.1124/mol.104.007807; PMID: 15673602
   PubMed Web of Science ®Google Scholar
• Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich SJ. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter. Mol Biol Cell 2007; 18:14 - 23; http://dx.doi.org/10.1091/mbc.E06-07-0596; PMID: 17065555
   PubMed Web of Science ®Google Scholar
• Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci U S A 2010; 107:1547 - 52; http://dx.doi.org/10.1073/pnas.0908801107; PMID: 20080644
   PubMed Web of Science ®Google Scholar
• Stagg J, Beavis PA, Divisekera U, Liu MC, Möller A, Darcy PK, et al. CD73-deficient mice are resistant to carcinogenesis. Cancer Res 2012; 72:2190 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-12-0420; PMID: 22396496
   PubMed Web of Science ®Google Scholar
• Park A, Stacy M. Istradefylline for the treatment of Parkinson’s disease. Expert Opin Pharmacother 2012; 13:111 - 4; http://dx.doi.org/10.1517/14656566.2012.643869; PMID: 22149371
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:e45; http://dx.doi.org/10.1093/nar/29.9.e45; PMID: 11328886
   PubMed Web of Science ®Google Scholar